Press releases
- Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
- Biohaven Announces Pricing of $230 Million Public Offering of Common Shares
- Biohaven Announces Proposed Public Offering of Common Shares
- Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates
- Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments
More ▼
Key statistics
As of last trade, Biohaven Ltd (ZH6:BER) traded at 37.20, 70.76% above the 52 week low of 21.79 set on Oct 05, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 37.20 |
---|---|
High | 37.20 |
Low | 37.20 |
Bid | 36.40 |
Offer | 38.00 |
Previous close | 37.00 |
Average volume | 102.22 |
---|---|
Shares outstanding | 88.26m |
Free float | 72.27m |
P/E (TTM) | -- |
Market cap | 3.52bn USD |
EPS (TTM) | -5.67 USD |
Data delayed at least 15 minutes, as of Apr 30 2024 07:08 BST.
More ▼